Vivos Therapeutics (VVOS) Net Income towards Common Stockholders (QoQ) (2020 - 2026)
Analysis
Vivos Therapeutics (VVOS) Net Income towards Common Stockholders (QoQ) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Align Technology | 11.30 Bn | 10.20 Bn | 757.43 Mn |
| 2 | Envista Holdings | 4.38 Bn | 3.26 Bn | 407.00 Mn |
| 3 | Dentsply Sirona | 2.27 Bn | 2.03 Bn | 493.00 Mn |
| 4 | Milestone Scientific | 37.81 Mn | 35.20 Mn | 1.56 Mn |
| 5 | Dror Ortho-Design | 9.77 Mn | 9.68 Mn | - |
| 6 | Vivos Therapeutics | 2.76 Mn | 790,007.20 | 2.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.65% |
| Mar 31, 2026 | -10.47% |
| Dec 31, 2025 | -28.78% |
| Sep 30, 2025 | -7.72% |
| Jun 30, 2025 | -29.74% |
| Mar 31, 2025 | -33.93% |
| Dec 31, 2024 | -10.28% |
| Sep 30, 2024 | -35.54% |
| Jun 30, 2024 | 48.71% |
| Mar 31, 2024 | 12.53% |
| Dec 31, 2023 | -105.54% |
| Sep 30, 2023 | 62.14% |
| Jun 30, 2023 | -224.60% |
| Mar 31, 2023 | 72.03% |
| Dec 31, 2022 | -12.05% |
| Sep 30, 2022 | 22.28% |
| Jun 30, 2022 | -31.16% |
| Mar 31, 2022 | 27.89% |
| Dec 31, 2021 | -35.58% |
| Sep 30, 2021 | -34.88% |